P01 AI097092/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2012	1
2013	14
2014	16
2015	18
2016	19
2017	13
2018	21
2019	25
2020	21
2021	23
2022	14
2023	5
2024	2

1

Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in quadrivalent influenza vaccine vaccinated mice.

Jangra S, Lamoot A, Singh G, Laghlali G, Chen Y, Ye T, García-Sastre A, De Geest BG, Schotsaert M. Jangra S, et al. Front Immunol. 2024 Apr 22;15:1370564. doi: 10.3389/fimmu.2024.1370564. eCollection 2024. Front Immunol. 2024. PMID: 38711520 Free PMC article.

2

Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in QIV vaccinated mice.

Jangra S, Lamoot A, Singh G, Laghlali G, Chen Y, Yz T, García-Sastre A, De Geest BG, Schotsaert M. Jangra S, et al. bioRxiv [Preprint]. 2024 Jan 15:2024.01.14.575599. doi: 10.1101/2024.01.14.575599. bioRxiv. 2024. PMID: 38293047 Free PMC article. Preprint.

3

Sequential vaccinations with divergent H1N1 influenza virus strains induce multi-H1 clade neutralizing antibodies in swine.

Van Reeth K, Parys A, Gracia JCM, Trus I, Chiers K, Meade P, Liu S, Palese P, Krammer F, Vandoorn E. Van Reeth K, et al. Nat Commun. 2023 Nov 27;14(1):7745. doi: 10.1038/s41467-023-43339-3. Nat Commun. 2023. PMID: 38008801 Free PMC article.

4

Group 1 and group 2 hemagglutinin stalk antibody response according to age.

Sánchez-de Prada L, Sanz-Muñoz I, Sun W, Palese P, Ortiz de Lejarazu R, Eiros JM, García-Sastre A, Aydillo T. Sánchez-de Prada L, et al. Front Immunol. 2023 May 29;14:1194073. doi: 10.3389/fimmu.2023.1194073. eCollection 2023. Front Immunol. 2023. PMID: 37313413 Free PMC article.

5

An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.

Widge AT, Hofstetter AR, Houser KV, Awan SF, Chen GL, Burgos Florez MC, Berkowitz NM, Mendoza F, Hendel CS, Holman LA, Gordon IJ, Apte P, Liang CJ, Gaudinski MR, Coates EE, Strom L, Wycuff D, Vazquez S, Stein JA, Gall JG, Adams WC, Carlton K, Gillespie RA, Creanga A, Crank MC, Andrews SF, Castro M, Serebryannyy LA, Narpala SR, Hatcher C, Lin BC, O'Connell S, Freyn AW, Rosado VC, Nachbagauer R, Palese P, Kanekiyo M, McDermott AB, Koup RA, Dropulic LK, Graham BS, Mascola JR, Ledgerwood JE; VRC 321 study team. Widge AT, et al. Sci Transl Med. 2023 Apr 19;15(692):eade4790. doi: 10.1126/scitranslmed.ade4790. Epub 2023 Apr 19. Sci Transl Med. 2023. PMID: 37075129 Free PMC article. Clinical Trial.

6

A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.

Hemann EA, Knoll ML, Wilkins CR, Subra C, Green R, García-Sastre A, Thomas PG, Trautmann L, Ireton RC, Loo YM, Gale M Jr. Hemann EA, et al. J Immunol. 2023 May 1;210(9):1247-1256. doi: 10.4049/jimmunol.2300026. J Immunol. 2023. PMID: 36939421 Free PMC article.

7

Antigenic Landscape Analysis of Individuals Vaccinated with a Universal Influenza Virus Vaccine Candidate Reveals Induction of Cross-Subtype Immunity.

Meade P, Strohmeier S, Bermúdez-González MC, García-Sastre A, Palese P, Simon V, Krammer F. Meade P, et al. J Virol. 2023 Jan 31;97(1):e0107022. doi: 10.1128/jvi.01070-22. Epub 2022 Dec 19. J Virol. 2023. PMID: 36533948 Free PMC article. Clinical Trial.

8

RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine.

Jangra S, Laghlali G, Choi A, Rathnasinghe R, Chen Y, Yildiz S, Coughlan L, García-Sastre A, De Geest BG, Schotsaert M. Jangra S, et al. Front Immunol. 2022 Nov 8;13:974016. doi: 10.3389/fimmu.2022.974016. eCollection 2022. Front Immunol. 2022. PMID: 36426358 Free PMC article.

9

Immunodominance hierarchy after seasonal influenza vaccination.

Sánchez-de Prada L, Sanz-Muñoz I, de Lejarazu RO, Eiros JM, García-Sastre A, Aydillo T. Sánchez-de Prada L, et al. Emerg Microbes Infect. 2022 Dec;11(1):2670-2679. doi: 10.1080/22221751.2022.2135460. Emerg Microbes Infect. 2022. PMID: 36219456 Free PMC article.

10

Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface.

Zhu X, Han J, Sun W, Puente-Massaguer E, Yu W, Palese P, Krammer F, Ward AB, Wilson IA. Zhu X, et al. Proc Natl Acad Sci U S A. 2022 May 24;119(21):e2200821119. doi: 10.1073/pnas.2200821119. Epub 2022 May 20. Proc Natl Acad Sci U S A. 2022. PMID: 35594401 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

180 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Results by year